Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors

por Kreil, Thomas R.
Publicado 2015

Orthopox viruses and the safety margins of solvent‐detergent treated plasma‐derived medicinal products

por Kindermann, Johanna, Karbiener, Michael, Kreil, Thomas R.
Publicado 2022

Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry

por Turecek, Peter L., Hibbett, Deborah, Kreil, Thomas R.
Publicado 2022

Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cells

por Grillberger, Leopold, Kreil, Thomas R., Nasr, Sonia, Reiter, Manfred
Publicado 2009

Measuring the effectiveness of gaseous virus disinfectants

por Knotzer, Simone, Kindermann, Johanna, Modrof, Jens, Kreil, Thomas R.
Publicado 2015

Function matters: Coronavirus cross-binding antibodies do not cross-neutralize

por Farcet, Maria R., Schwaiger, Julia, Karbiener, Michael, Kreil, Thomas R.
Publicado 2022

Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC

por Farcet, Jean-Baptiste, Karbiener, Michael, Zelger, Leonhard, Kindermann, Johanna, Kreil, Thomas R.
Publicado 2023

West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States

por Planitzer, Christina B., Modrof, Jens, Yu, Mei-ying W., Kreil, Thomas R.
Publicado 2009

No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic

por Schwaiger, Julia, Karbiener, Michael, Aberham, Claudia, Farcet, Maria R, Kreil, Thomas R
Publicado 2020

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic( )

por Farcet, Maria R, Karbiener, Michael, Schwaiger, Julia, Ilk, Reinhard, Kreil, Thomas R
Publicado 2021

Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism

por Weidner, Lisa, Kalser, Julia, Kreil, Thomas R., Jungbauer, Christof, Mayr, Wolfgang R.
Publicado 2021

Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis

por Lackner, Cornelia, Karbiener, Michael, Faltner, Lukas, Farcet, Maria R., Kreil, Thomas R.
Publicado 2022

Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe( )

por Farcet, Maria R, Karbiener, Michael, Knotzer, Simone, Schwaiger, Julia, Kreil, Thomas R
Publicado 2022

Selection of recombinant MVA by rescue of the essential D4R gene

por Ricci, Patricia S, Schäfer, Birgit, Kreil, Thomas R, Falkner, Falko G, Holzer, Georg W
Publicado 2011

Synthesis of “Nereid,” a new phenol‐free detergent to replace Triton X‐100 in virus inactivation

por Farcet, Jean‐Baptiste, Kindermann, Johanna, Karbiener, Michael, Scheinecker, Richard, Kostner, Otto, Kreil, Thomas R.
Publicado 2020

SARS-CoV-2 and the safety margins of cell-based biological medicinal products

por Modrof, Jens, Kerschbaum, Astrid, Farcet, Maria R., Niemeyer, Daniela, Corman, Victor M., Kreil, Thomas R.
Publicado 2020

Truly continuous low pH viral inactivation for biopharmaceutical process integration

por Martins, Duarte L., Sencar, Jure, Hammerschmidt, Nikolaus, Flicker, Andreas, Kindermann, Johanna, Kreil, Thomas R., Jungbauer, Alois
Publicado 2020

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations

por Jungbauer, Christof, Weseslindtner, Lukas, Weidner, Lisa, Gänsdorfer, Simon, Farcet, Maria R., Gschaider‐Reichhart, Eva, Kreil, Thomas R.
Publicado 2020

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines

por Karbiener, Michael, Farcet, Maria R., Zollner, Andreas, Masuda, Taisei, Mori, Mitsuhiro, Moschen, Alexander R., Kreil, Thomas R.
Publicado 2022

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins

por Karbiener, Michael, Farcet, Maria R, Schwaiger, Julia, Powers, Nicholas, Lenart, James, Stewart, Joseph M, Tallman, Hema, Kreil, Thomas R
Publicado 2021